Year |
Citation |
Score |
2024 |
Kambali M, Li Y, Unichenko P, Feria Pliego JA, Yadav R, Liu J, McGuinness P, Cobb JG, Wang M, Nagarajan R, Lyu J, Vongsouthi V, Jackson CJ, Engin E, Coyle JT, et al. An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function. Molecular Psychiatry. PMID 39210012 DOI: 10.1038/s41380-024-02711-5 |
0.707 |
|
2023 |
Kambali M, Li Y, Unichenko P, Pliego JF, Yadav R, Liu J, McGuinness P, Cobb JG, Wang M, Nagarajan R, Lyu J, Vongsouthi V, Jackson CJ, Engin E, Coyle JT, et al. A marker chromosome in psychosis identifies glycine decarboxylase (GLDC) as a novel regulator of neuronal and synaptic function in the hippocampus. Biorxiv : the Preprint Server For Biology. PMID 37398055 DOI: 10.1101/2023.05.29.542745 |
0.686 |
|
2023 |
Engin E. GABA receptor subtypes and benzodiazepine use, misuse, and abuse. Frontiers in Psychiatry. 13: 1060949. PMID 36713896 DOI: 10.3389/fpsyt.2022.1060949 |
0.344 |
|
2021 |
Benham RS, Choi C, Hodgson NW, Hewage NB, Kastli R, Donahue RJ, Muschamp JW, Engin E, Carlezon WA, Hensch TK, Rudolph U. α2-containing γ-aminobutyric acid type A receptors promote stress resiliency in male mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34408277 DOI: 10.1038/s41386-021-01144-w |
0.602 |
|
2020 |
Engin E, Sigal M, Benke D, Zeller A, Rudolph U. Bidirectional regulation of distinct memory domains by α5-subunit-containing GABA receptors in CA1 pyramidal neurons. Learning & Memory (Cold Spring Harbor, N.Y.). 27: 423-428. PMID 32934095 DOI: 10.1101/Lm.052084.120 |
0.633 |
|
2018 |
Engin E, Benham RS, Rudolph U. An Emerging Circuit Pharmacology of GABA Receptors. Trends in Pharmacological Sciences. PMID 29903580 DOI: 10.1016/J.Tips.2018.04.003 |
0.617 |
|
2017 |
Benham RS, Hewage NB, Suckow RF, Engin E, Rudolph U. Corrigendum to "Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABAA receptors" [Behav. Brain Res. 332 (2017) 172-179]. Behavioural Brain Research. PMID 29070432 DOI: 10.1016/J.Bbr.2017.10.006 |
0.616 |
|
2017 |
Benham RS, Hewage NB, Suckow RF, Engin E, Rudolph U. Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABAA receptors. Behavioural Brain Research. PMID 28587819 DOI: 10.1016/J.Bbr.2017.05.063 |
0.582 |
|
2016 |
Behlke LM, Foster RA, Liu J, Benke D, Benham RS, Nathanson A, Yee BK, Zeilhofer HU, Engin E, Rudolph U. A Pharmaco-Genetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27067130 DOI: 10.1038/Npp.2016.49 |
0.6 |
|
2016 |
Engin E, Smith KS, Gao Y, Nagy D, Foster RA, Tsvetkov E, Keist R, Crestani F, Fritschy JM, Bolshakov VY, Hajos M, Heldt SA, Rudolph U. Modulation of anxiety and fear via distinct intrahippocampal circuits. Elife. 5. PMID 26971710 DOI: 10.7554/Elife.14120 |
0.762 |
|
2016 |
Engin E, Smith KS, Gao Y, Nagy D, Foster RA, Tsvetkov E, Keist R, Crestani F, Fritschy J, Bolshakov VY, Hajos M, Heldt SA, Rudolph U. Author response: Modulation of anxiety and fear via distinct intrahippocampal circuits Elife. DOI: 10.7554/Elife.14120.023 |
0.689 |
|
2015 |
Engin E, Zarnowska ED, Benke D, Tsvetkov E, Sigal M, Keist R, Bolshakov VY, Pearce RA, Rudolph U. Tonic Inhibitory Control of Dentate Gyrus Granule Cells by α5-Containing GABAA Receptors Reduces Memory Interference. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 13698-712. PMID 26446222 DOI: 10.1523/Jneurosci.1370-15.2015 |
0.737 |
|
2015 |
Rodgers FC, Zarnowska ED, Laha KT, Engin E, Zeller A, Keist R, Rudolph U, Pearce RA. Etomidate Impairs Long-Term Potentiation In Vitro by Targeting α5-Subunit Containing GABAA Receptors on Nonpyramidal Cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 9707-16. PMID 26134653 DOI: 10.1523/Jneurosci.0315-15.2015 |
0.748 |
|
2014 |
Riccio A, Li Y, Tsvetkov E, Gapon S, Yao GL, Smith KS, Engin E, Rudolph U, Bolshakov VY, Clapham DE. Decreased anxiety-like behavior and Gαq/11-dependent responses in the amygdala of mice lacking TRPC4 channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 3653-67. PMID 24599464 DOI: 10.1523/Jneurosci.2274-13.2014 |
0.738 |
|
2014 |
Engin E, Bakhurin KI, Smith KS, Hines RM, Reynolds LM, Tang W, Sprengel R, Moss SJ, Rudolph U. Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1805-15. PMID 24553732 DOI: 10.1038/Npp.2014.41 |
0.629 |
|
2014 |
Benham RS, Engin E, Rudolph U. Diversity of neuronal inhibition: a path to novel treatments for neuropsychiatric disorders. Jama Psychiatry. 71: 91-3. PMID 24196284 DOI: 10.1001/Jamapsychiatry.2013.3059 |
0.598 |
|
2013 |
Engin E, Bakhurin KI, Smith KS, Hines RM, Reynolds LM, Tang W, Sprengel R, Moss SJ, Rudolph U. S.6.1 - NEURAL BASIS OF BENZODIAZEPINE REWARD Behavioural Pharmacology. 24: e6-e7. DOI: 10.1097/01.Fbp.0000434704.76389.C2 |
0.496 |
|
2012 |
Engin E, Liu J, Rudolph U. α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders. Pharmacology & Therapeutics. 136: 142-52. PMID 22921455 DOI: 10.1016/J.Pharmthera.2012.08.006 |
0.616 |
|
2012 |
Reynolds LM, Engin E, Tantillo G, Lau HM, Muschamp JW, Carlezon WA, Rudolph U. Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2531-40. PMID 22763624 DOI: 10.1038/Npp.2012.115 |
0.617 |
|
2012 |
Smith KS, Engin E, Meloni EG, Rudolph U. Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice. Neuropharmacology. 63: 250-8. PMID 22465203 DOI: 10.1016/J.Neuropharm.2012.03.001 |
0.644 |
|
2011 |
Yeung M, Engin E, Treit D. Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions. Psychopharmacology. 216: 557-67. PMID 21424237 DOI: 10.1007/S00213-011-2248-X |
0.735 |
|
2011 |
Drexler B, Antkowiak B, Engin E, Rudolph U. Identification and characterization of anesthetic targets by mouse molecular genetics approaches. Canadian Journal of Anaesthesia = Journal Canadien D'Anesthã©Sie. 58: 178-90. PMID 21174184 DOI: 10.1007/S12630-010-9414-1 |
0.578 |
|
2010 |
Treit D, Engin E, McEown K. Animal models of anxiety and anxiolytic drug action. Current Topics in Behavioral Neurosciences. 2: 121-60. PMID 21309109 DOI: 10.1007/7854_2009_17 |
0.72 |
|
2009 |
Engin E, Treit D. Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors. Psychopharmacology. 206: 281-9. PMID 19609508 DOI: 10.1007/S00213-009-1605-5 |
0.681 |
|
2009 |
Engin E, Treit D, Dickson CT. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience. 161: 359-69. PMID 19321151 DOI: 10.1016/J.Neuroscience.2009.03.038 |
0.66 |
|
2009 |
Engin E, Treit D, Dickson CT. Corrigendum to "anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models". [Neuroscience 161 (2009) 359-369] (DOI:10.1016/j.neuroscience.2009.03.038) Neuroscience. 162: 1438-1439. DOI: 10.1016/J.Neuroscience.2009.06.007 |
0.628 |
|
2008 |
Engin E, Stellbrink J, Treit D, Dickson CT. Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence. Neuroscience. 157: 666-76. PMID 18940236 DOI: 10.1016/J.Neuroscience.2008.09.037 |
0.67 |
|
2008 |
Engin E, Treit D. Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus. Neuropeptides. 42: 411-21. PMID 18508119 DOI: 10.1016/J.Npep.2008.04.004 |
0.686 |
|
2008 |
Engin E, Treit D. The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 1399-419. PMID 18495312 DOI: 10.1016/J.Pnpbp.2008.03.020 |
0.7 |
|
2007 |
Engin E, Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behavioural Pharmacology. 18: 461-70. PMID 17762514 DOI: 10.1097/Fbp.0B013E3282D28F6F |
0.676 |
|
2007 |
Engin E, Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behavioural Pharmacology. 18: 365-74. PMID 17762507 DOI: 10.1097/Fbp.0B013E3282De7929 |
0.698 |
|
Show low-probability matches. |